Esophagus News

April is Esophageal Cancer Awareness Month; to help raise awareness, the Esophageal Cancer Action Network has hosted various events throughout the month and is offering kits for individuals to host their own events to celebrate.

Prolonged radiotherapy duration appeared associated with inferior DFS among a cohort of patients with esophageal cancer, according to study results published in JAMA Network Open.

Patients with eosinophilic esophagitis taking a first-in-class peptide during a phase 2a randomized, double-blind clinical trial safely experienced reductions in esophageal intraepithelial eosinophil count, according to a press release.

Most patients who developed eosinophilic esophagitis during oral immunotherapy experienced resolution in their EoE symptoms without stopping OIT, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with food allergies and eosinophilic esophagitis have more food allergies, more allergic reactions and increased reaction severity, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

SAN ANTONIO — A high proportion of patients with eosinophilic esophagitis also had simultaneous atopic or allergic comorbid conditions, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The elimination of animal milk alone was an effective first step in dietary therapy for patients with eosinophilic esophagitis, according to research published in The Lancet Gastroenterology & Hepatology.

A machine learning model may aid the detection and classification of tertiary lymphoid structures associated with gastrointestinal cancers based on routine tissue slides, according to research in JAMA Network Open.

The FDA has rejected Phathom Pharmaceutical’s vonoprazan new drug application for erosive esophagitis, as well as its post-approval supplement for Helicobacter pylori, due to the presence of nitrosamine impurities.

Patients with systemic sclerosis who report more severe reflux symptoms demonstrate worse interstitial lung disease outcomes despite receiving standard therapy, according to data published in Arthritis Care & Research.